These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10515775)

  • 1. Interferon for tufted angioma.
    Wollina U
    Pediatr Dermatol; 1999; 16(4):338. PubMed ID: 10515775
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of tufted angioma with interferon alfa: role of bFGF.
    Robenzadeh A; Don PC; Weinberg JM
    Pediatr Dermatol; 1998; 15(6):482. PubMed ID: 9875976
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases.
    Marler JJ; Rubin JB; Trede NS; Connors S; Grier H; Upton J; Mulliken JB; Folkman J
    Pediatrics; 2002 Feb; 109(2):E37. PubMed ID: 11826247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon alpha in the treatment of cutaneous T-cell lymphoma].
    Dréno B
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S27-30. PubMed ID: 16385896
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of adjuvant interferon in high risk melanoma patients.
    Dermatol Surg; 2000 Jun; 26(6):607-8. PubMed ID: 10848951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Underutilization of anticancer agents--an example].
    Strannegård O; Thorén FB
    Lakartidningen; 2010 Dec 8-14; 107(49):3150; discussion 3150-1. PubMed ID: 21280349
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of deep tufted angioma to interferon alfa.
    Suarez SM; Pensler JM; Paller AS
    J Am Acad Dermatol; 1995 Jul; 33(1):124-6. PubMed ID: 7601929
    [No Abstract]   [Full Text] [Related]  

  • 8. Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma.
    Wheatley K; Ives N; Hancock B; Gore M
    J Clin Oncol; 2002 Oct; 20(19):4120-1; author reply 4121-2. PubMed ID: 12351611
    [No Abstract]   [Full Text] [Related]  

  • 9. Airway haemangioma treated with interferon-alpha 2a.
    Suskan E; Tekin D; Atay G; Yağmurlu A; Uğur H; Taçyildiz N
    Acta Paediatr; 2008 Apr; 97(4):393-4. PubMed ID: 18307545
    [No Abstract]   [Full Text] [Related]  

  • 10. Pegylated interferon-α2b for local control of Langerhans cell sarcoma.
    Ishitsuka Y; Iwamoto K; Oya K; Nakamura Y; Watanabe R; Okiyama N; Fujisawa Y; Fujimoto M
    Eur J Dermatol; 2018 Dec; 28(6):835-836. PubMed ID: 30355544
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head.
    Spieth K; Gille J; Kaufmann R
    Arch Dermatol; 1999 Sep; 135(9):1035-7. PubMed ID: 10490107
    [No Abstract]   [Full Text] [Related]  

  • 13. Grand mal seizure induced by interferon-alpha-2b.
    Kors C; Milling A; Hofmann M; Sterry W; Trefzer U
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):473-4. PubMed ID: 16643159
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
    Mohr P; Hauschild A; Trefzer U; Weichenthal M
    J Clin Oncol; 2009 Aug; 27(24):e70; author reply e71. PubMed ID: 19620476
    [No Abstract]   [Full Text] [Related]  

  • 15. [After removal of a malignant melanoma. Enhancing the immune system!].
    MMW Fortschr Med; 1999 Nov; 141(44):66. PubMed ID: 10912153
    [No Abstract]   [Full Text] [Related]  

  • 16. Use and abuse of statistics in evidence-based medicine.
    Kirkwood JM; Ibrahim J; Sondak VK; Ernstoff MS; Flaherty L; Haluska FJ
    J Clin Oncol; 2002 Oct; 20(19):4122-3; author reply 4123-4. PubMed ID: 12351612
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapidly progressive classic Kaposi sarcoma in an adolescent: response to interferon alfa therapy and biological correlates.
    Guttman-Yassky E; Kra-Oz Z; Cohen A; Sattinger Y; Rot T; Sarid R; Bergman R
    Br J Dermatol; 2006 Mar; 154(3):555-7. PubMed ID: 16445793
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose adjuvant interferon therapy for melanoma.
    Licata AG
    Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Node positive melanoma--a positive note?
    Kelly J; Kerin MJ
    Surgeon; 2012 Apr; 10(2):63-4. PubMed ID: 22385525
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.